Double chin, or submental fullness, is a common, yet undertreated facial aesthetic condition. Submental fullness is not limited to people who are overweight and is often resistant to diet and exercise. It can affect men or women of average weight and can be caused by aging, genetics and weight gain. Submental fullness can make those affected seem heavier than they are and lead to an older, unbalanced facial appearance. In the past treatment for submental fullness was limited to invasive options like surgery and liposuction or energy devices that offered inconsistent and temporary results.
HOW WE TREAT IT
Belkyra™ offers patients a non-invasive treatment option that can deliver outstanding facial contouring. Belkyra™ is an injectable solution that permanently destroys fat cells. It contains no human or animal-derived substances and is extremely safe when administered by qualified, experienced physicians. Under its US trade name, Kybella™, Belkyra™ has been the focus of a global clinical development program involving over 20 clinical studies with more than 2,600 patients worldwide. Dr. Muhnand Dr. Rosen are part of a small, select group of specialists chosen by Allergan to lead the launch of this product in Canada.